H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents(CTSO)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001410578-24-000201 Act: 34 Size: 11 MB 网页链接
$Cytosorbents(CTSO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001033475-24-000004 Act: 34 Size: 19 KB 网页链接
$Cytosorbents(CTSO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001398344-24-002888 Act: 34 Size: 64 KB 网页链接
$Cytosorbents(CTSO)$ 8-K Current report, items 3.01, 8.01, and 9.01 Accession Number: 0001104659-24-004548 Act: 34 Size: 273 KB 网页链接
$Cytosorbents(CTSO)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001821268-24-000004 Act: 34 Size: 30 KB 网页链接
$Cytosorbents(CTSO)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001104659-23-130093 Act: 34 Size: 271 KB 网页链接
$Cytosorbents(CTSO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-126432 Size: 9 KB 网页链接
$Cytosorbents(CTSO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-126421 Size: 9 KB 网页链接
$Cytosorbents(CTSO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-126424 Size: 8 KB 网页链接
$Cytosorbents(CTSO)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-23-126428 Size: 8 KB 网页链接